iBio, Inc. announced that it has entered into an agreement with returning investor Lincoln Park Capital Fund, LLC to issue 10,000,000 shares at an issue price of $1 per share for the gross proceeds of $10,000,000 on August 4, 2023. The Purchase Agreement also prohibits the Company from directing Lincoln Park to purchase any shares of Common Stock if those shares, when aggregated with all other shares of Common Stock then beneficially owned by Lincoln Park, would result in Lincoln Park beneficially owning more than 4.99% of the outstanding shares of Common Stock. The shares of Common Stock that have been and may be issued under the Purchase Agreement are being offered and sold in a transaction exempt from registration under the Securities Act in reliance on Section 4(a)(2) thereof and Rule 506(b) of Regulation D thereunder.